Tag: multiple sclerosis test

Biomarker, Innovation

Quanterix receives Breakthrough Device status for multiple sclerosis test

April 25, 2022


Quanterix has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for its Simoa neurofilament light chain (NfL) plasma test for multiple sclerosis (MS). The blood-based assay has obtained the designation as a prognostic aid for evaluating […]